Varian Medical Systems, Inc. – Shareholder/Analyst CallSeeking AlphaYou have some uterine, gynecological cancers in subcontinent Africa as well as in India, and then of course, you have lung and liver again over in Asia Pac. What these numbers have don…
Chuck Muncie, former Saints, Chargers All-Pro running back, dead of heart … – New York Daily News
 New York Daily News |
Chuck Muncie, former Saints, Chargers All-Pro running back, dead of heart …
New York Daily News Muncie family spokesman Vintage Foster of AMF Media Group in San Ramon, Calif., said Muncie died at his Los Angeles-area home on Monday from heart failure. Muncie was the Saints’ first-round pick, third overall, out of California in 1976. He played 4½ … Chuck Muncie, former Cal and NFL star, dead at 60San Jose Mercury News Chuck Muncie Passes At 60; Cal Bears LegendFootball Reporters Online |
Addition of rituximab to DA-EPOCH negated need for radiotherapy in primary … – Healio
Addition of rituximab to DA-EPOCH negated need for radiotherapy in primary …HealioThe addition of rituximab to dose-adjusted etoposide, doxorubicin, and cyclophosphamide plus vincristine and prednisone prevented the need for radiotherapy in most pati…
How do you define 'old'? – Ahmedabad Mirror
|
How do you define ‘old’?
Ahmedabad Mirror Nevertheless, medicine has made numerous strides to increase life expectancy and the expectancy in India is approximately 65 years. Ageing is actually a biological process affecting all cellular function, making them less efficient. Ageing is … |
What's Driving the Surge in Drug Research for "Orphan" Diseases? – Healthline – Healthline
 Healthline |
What’s Driving the Surge in Drug Research for “Orphan” Diseases? – Healthline
Healthline For example, Biogen Idec’s drug Rituximab, a breakthrough treatment for B-cell lymphoma, is projected to generate $34 billion in revenue, according to Thomson Reuters. The drug has since proven helpful in treating rheumatoid arthritis, multiple … |
Leukaemia cure lies in cancer pill? – Times of India
Leukaemia cure lies in cancer pill?Times of IndiaCity scientists Aditi Karmakar, Sudeshna Gangopadhyay and GS Bhattacharya have found out that rapamycin – a drug commonly used in the treatment of liver cancer – inhibits mTOR, the pathway for a multi-dr…
'Off-the-shelf' virus-specific T-cells fight viral infections in stem cell … – BCM News
 TopNews Arab Emirates |
‘Off-the-shelf’ virus-specific T-cells fight viral infections in stem cell …
BCM News They used cells from 18 of these lines to treat 50 patients from eight centers across the country that had undergone a stem cell transplant and were suffering from a severe viral infection that had not responded to conventional treatment. Commonly … Majority of children readmitted to hospital after stem cell transplantOncology Nurse Advisor Nobel Prize Rockets Stem Cell Program to New HeightsUCSF News Services Derriford Hospital’s £3m stem cell isolation unit praisedBBC News Proactive Investors USA & Canada all 17 news articles » |
Cancer may become killer disease by 2015: experts – The Hindu
The HinduCancer may become killer disease by 2015: expertsThe HinduDescribing the cancers of breast, lung, colon and prostate as lifestyle diseases, he said essentially what was happening in the West 20-25 years ago was happening in India now. Control …
Turn Mahalaxmi race course into a park: Sena – Livemint
 Livemint |
Turn Mahalaxmi race course into a park: Sena
Livemint The lease, held by the Royal Western India Turf Club (RWITC), one of the Mumbai’s most exclusive clubs, expires on 31 May. On 4 May, city … Debi Goenka, executive trustee of non-profit organization Conservation Action Trust that lobbies for … Convert Mumbai’s Mahalaxmi Race Course into theme park, says Uddhav …NDTV |
Giant Retailers Agree to Improve Safety at Bangladesh Garment Factories – FairWarning
|
Giant Retailers Agree to Improve Safety at Bangladesh Garment Factories
FairWarning U.S. prosecutors said the guilty plea by Ranbaxy USA Inc., a unit of India’s largest pharmaceutical company, represents the largest financial penalty against a generic drug company for violations of the Food, Drug and Cosmetic Act, which prohibits the … |